Reduced Calcium Dialysis Fluids: What'S the Point?

Parker A. , Nolph K. Magnesium and calcium transfer during continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1980; 26: 194–6.

Weinreich T. , Rambausek M. , Ritz E. Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant 1991; 6: 843–5.

Martis L. , Serkes K. , Nolph K. Calcium carbonate as a phosphate binder: is there a need to adjust peritoneal calcium concentrations for patients using calcium carbonate? Perit Dial Int 1989; 9: 325–8.

Fournier A. , Arnaud C. , Johnson W. Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. J Clin Invest 1971; 50: 599–605.

Slatopolsky E. , Delmez J. Pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 1989; 2: 22936.

Slatopolsky E. Overall view in the pathogenesis of secondary hyperparathyroidism in uremia (Abstract). Renal Bone Disease, Parathyroid Hormone, and Vitamin D Symposium. Official satellite to the XIIIth ICN. Seville, Spain, 1995.

Hernandez A. , Salido E. , Rodriguez M. , Torres A. High phosphate diet increases preproPTH mRNA independent of 1,25–(OH)2D3 and calcium in normal rats (Abstract). Renal Bone Disease, Parathyroid Hormone, and Vitamin D Symposium. Official satellite to the XIIIth ICN. Seville, Spain, 1995.

Sudhaker Rao D. , Goggins M. , Bhat S. Factors affecting the long-term response to intravenous calcitriol in patients on hemodialysis (Abstract). Renal Bone Disease, Parathyroid Hormone, and Vitamin D Symposium. Official satellite to the XIIIth ICN. Seville, Spain, 1995.

Hamdy N. , Boletis J. , Charlesworth D. Low calcium dialysate increases the tolerance to vitamin D in peritoneal dialysis. Contrib Nephrol 1991; 89: 190–8.

Hutchison A. , Freemont A. , Boulton H. , Gokal R. Lowcalcium dialysis fluid and oral calcium carbonate in CAPD: a method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia. Nephrol Dial Transplant 1992; 7: 1219–25.

Carozzi S. , Nasini M. , Santoni O. , Pietrucci A. Low and high- turnover bone disease in CAPD: effects of lowcalcium peritoneal dialysis solution. PeritDialInt 1993; 13(Suppl 2): 473–5.

Honkanen E. , Kala A. , Gronhagen-Riska C. , Ikaheimo R. CAPD with low calcium dialysate and calcium carbonate: results of a 24-weekstudy. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 356–61.

Rotellar C. , Kinsel V. , Goggins M. Does lowcalcium dialysate accelerate secondary hyperparathyroidism in CAPD patients? Perit Dial Int 1993; 13: (Suppl 2): 471–2.

Weinreich T. , Ritz E. , Passlick-Deetjen J. Long-term dialysis with low calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Perit Dial Int 1996; 16: 260–69.

Hutchison A. , Gokal R. Calcium, phosphate and renal osteodystrophy. In: Gokal R. , Nolph K. , eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic, 1994: 544–7.

Cunningham J. , Beer J. , Coldwell R. , Noonan K. , Sawyer N. , Makin H. Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol. Nephrol Dial Transplant 1992; 7(1): 63–8.

Hutchison A. , Merchant M. , Boulton H. , Hinchcliffe R. , Gokal R. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium 1.25 mmol/L magnesium dialysis fluid. Perit Dial Int 1993; 13: 219–23.